Endoron Medical
Founded 2019 · 14 employees on LinkedIn · 1 known investors
Find your way into Endoron Medical
Endoron Medical develops transcatheter anchoring and sealing devices for aortic procedures, including Aortodock (a nitinol docking system to stabilize transcatheter valves in low-calcium aortic regurgitation and stenosis anatomies) and Aortoseal (a multi-stapling fixation and sealing system for endovascular aneurysm repair grafts). Its products serve physicians treating patients across the aortic continuum from TAVR to EVAR.
Investors · 1
Sofinnova Partnerslisted by Sofinnova PartnersParis · $540K – $27M
How we know: Sofinnova Partners's portfolio page · funding news · businesswire.com · Not right? Tell us
Funding
SEC filings, press & company announcements$10M disclosed across 1 of 2 rounds · 2024
- $10MSeries AJul 2024 · 4 sources
Sofinnova Partners (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Endoron Medical do?
- Endoron Medical develops transcatheter anchoring and sealing devices for aortic procedures, including Aortodock (a nitinol docking system to stabilize transcatheter valves in low-calcium aortic regurgitation and stenosis anatomies) and Aortoseal (a multi-stapling fixation and sealing system for endovascular aneurysm repair grafts). Its products serve physicians treating patients across the aortic continuum from TAVR to EVAR.
- Who are Endoron Medical's investors?
- Endoron Medical's investors include Sofinnova Partners.
- How much funding has Endoron Medical raised?
- Endoron Medical has disclosed $10M raised across 1 of its 2 known rounds.

